Imipenem therapy of brain abscesses

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 15, Issue 8, 1996, Pages 653-657

  Asensi, V ^a   Carton, J A ^a   Maradona, J A ^a   Asensi, J M ^a   Ferez, F ^a   Redondo, P ^a   Lopez A ^a   Arribas, J M ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CLOXACILLIN; IMIPENEM; METRONIDAZOLE; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BRAIN ABSCESS; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT;

EID: 10144222879     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691152     Document Type: Article

References (15)

1. Brewer NS, MacCarty CS, Wellman WE: Brain abscess: a review of recent experience. Annals of Internal Medicine 1975, 82: 571-576.
2. Yang SY: Brain abscess: a review of 400 cases. Journal of Neurosurgery 1981, 53: 794-799.
3. Chun CH, Johnson JD, Hofstetter M, Raff MJ: Brain abscess. A study of 45 consecutive cases. Medicine 1986, 65:415-431.
4. Seydoux C, Francioli P: Bacterial abscesses: factors influencing mortality and sequelae. Clinical Infectious Diseases 1992, 15: 394-401.
5. Bloom WH, Tuazon C: Successful treatment of multiple brain abscesses with antibiotics alone. Reviews of Infectious Diseases 1985, 7: 189-199.
6. Sjolin J, Lilja A, Eriksson N, Arneborn P, Cors O: Treatment of brain abscess with cefotaxime and metronidazole: prospective study of 15 consecutive patients. Clinical Infectious Diseases 1993, 17: 857-863.
7. Carton JA, Pérez F, Maradona JA, Méndez FJ: Successful treatment of recurrent cerebral empyema and brain abscesses with imipenem. European Journal of Clinical Microbiology 1987, 6: 578-579.
8. Birnbaun J, Kahan FM, Kropp H, McDonald JS: Carbapenems, a new class of beta-lactam antibiotics. American Journal of Medicine 1985, 78, Supplement 6A: 3-21.
9. Geddes AM, Stille W: Imipenem: the first thienamycin antibiotic. Reviews of Infectious Diseases 1985, 7, Supplement 3: 353-366.
10. Geddes AM, Oylance PJ: Clinical experience with imipenem/cilastatin: a 5-year overview. Current Opinions in Infectious Diseases 1991, 4, Supplement 1: 3-9.
11. Modai J, Vittecoq D, Decazes JM, Meulemans A: Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis. Journal of Antimicrobial Chemotherapy 1985, 16: 751-755.
12. Calandra G, Lydick E, Carugan J, Weiss J, Guess H: Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin. American Journal of Medicine 1988, 89: 911-918.
13. Edberg SC, Barry AL, Young LS, Morello JA: Therapeutic drug monitoring: antimicrobial agents. In: Morello JA (ed): Cumitech 20. American Society for Microbiology, Washington DC, 1984, p. 1-20.
14. Kropp H, Gerckens, I, Sundelof JG, Kahan FM: Antibacterial activity of imipenem: the first thienamycin antibiotic. Reviews of Infectious Diseases 1995, 7, Supplement 3: 389-410.
15. Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP: Prospective surveillance of imipenem-cilastatin use and associated seizures using a hospital information system. Annals of Pharmacotherapy 1993, 27: 497-501.